Evonik Industries AG Share Price

Equities

EVK

DE000EVNK013

Specialty Chemicals

Market Closed - Xetra 09:05:01 14/06/2024 pm IST 5-day change 1st Jan Change
18.24 EUR -2.36% Intraday chart for Evonik Industries AG -0.98% -1.41%

Financials

Sales 2024 * 15.41B 16.49B 1,378B Sales 2025 * 15.83B 16.95B 1,416B Capitalization 8.5B 9.1B 760B
Net income 2024 * 483M 517M 43.2B Net income 2025 * 639M 684M 57.15B EV / Sales 2024 * 0.77 x
Net Debt 2024 * 3.34B 3.57B 299B Net Debt 2025 * 3.18B 3.41B 285B EV / Sales 2025 * 0.74 x
P/E ratio 2024 *
17.9 x
P/E ratio 2025 *
13.4 x
Employees 33,090
Yield 2024 *
6.43%
Yield 2025 *
6.49%
Free-Float 53.48%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.36%
1 week-0.98%
Current month-9.57%
1 month-11.93%
3 months+6.92%
6 months+1.19%
Current year-1.41%
More quotes
1 week
18.19
Extreme 18.19
19.10
1 month
18.19
Extreme 18.19
20.47
Current year
16.68
Extreme 16.68
20.96
1 year
15.79
Extreme 15.79
20.96
3 years
15.79
Extreme 15.79
29.93
5 years
15.13
Extreme 15.13
31.00
10 years
15.13
Extreme 15.13
37.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 01/13/01
Director of Finance/CFO 50 -
Investor Relations Contact - 01/11/01
Members of the board TitleAgeSince
Director/Board Member 71 02/21/02
Chairman 68 23/18/23
Director/Board Member 53 01/22/01
More insiders
Date Price Change Volume
14/24/14 18.24 -2.36% 952,292
13/24/13 18.68 -1.68% 1,190,107
12/24/12 19 +0.96% 1,115,531
11/24/11 18.82 +1.67% 1,198,230
10/24/10 18.51 +0.49% 867,402

Delayed Quote Xetra, June 14, 2024 at 09:05 pm IST

More quotes
Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
18.24 EUR
Average target price
21.65 EUR
Spread / Average Target
+18.71%
Consensus